A backtest simulates a strategy by applying a defined set of rules to historical data and tracking the hypothetical portfolio that would have resulted. At its core, it answers one question: if I had followed these rules in the past, what would have happened?<\/strong><\/p>\n\n\n\n A simple example: suppose your strategy is to buy the top 20 stocks ranked by 6-month price momentum from the Nifty 500 universe, hold them for one month, and then rebalance. A backtest would go back to, say, January 2020, identify which 20 stocks had the highest 6-month returns as of that date, simulate buying them in equal weights, hold for one month, sell, identify the new top 20 as of February 2020, buy again, and so on through September 2026. The result is a simulated portfolio with a complete return history.<\/p>\n\n\n\n That return history can then be compared to a benchmark, typically the Nifty 50 or Nifty 500, and analysed across dozens of metrics: total return, annualised CAGR, volatility, maximum drawdown, win rate, Sharpe Ratio, and more.<\/p>\n\n\n\n The purpose is not to prove the strategy worked in the past; that is easy to engineer with enough data manipulation. The purpose is to build a well-founded expectation of how the strategy will behave going forward<\/strong>, based on how it behaved across a range of historical market conditions.<\/p>\n\n\n\n The most important, and most commonly violated, principle in backtesting is the use of bias-free, point-in-time data<\/strong>. This is what separates a backtest that means something from one that produces an illusion of performance.<\/p>\n\n\n\n Survivorship bias occurs when a backtest uses only the companies that currently exist<\/strong> in a universe, ignoring the companies that existed historically but have since been delisted, merged, or gone bankrupt. It is one of the most pervasive problems in retail backtesting.<\/p>\n\n\n\n Consider the Nifty 500. The current Nifty 500 is a list of the 500 companies that are successful enough to be in the index today. But in 2015, the Nifty 500 contained many different companies \u2014 some of which have since been removed because they underperformed, became insolvent, or were acquired. A backtest that uses the current Nifty 500 constituents and goes back to 2015 is effectively selecting its investment universe from the future<\/strong>; it knows which companies survived, and naturally avoids the ones that did not.<\/p>\n\n\n\n The result is an artificially inflated return, because the backtest never holds any company that went to zero or was delisted at a loss. In reality, any investor running that strategy in 2015 would have owned some of those companies. The backtest does not reflect what they would have experienced.<\/p>\n\n\n\n A survivorship-bias-free backtest uses a complete historical universe<\/strong> that includes all companies that were in the investment universe at the time, including those that subsequently failed. This is what separates a meaningful backtest from a flattering one.<\/p>\n\n\n\n Look-ahead bias occurs when a backtest uses data that would not have been available to an investor at the time the decision was being made. This is subtler than survivorship bias but equally damaging.<\/p>\n\n\n\n The most common example: financial data. A company’s Q1 FY26 results are filed with BSE in August 2026. If a backtest uses those results to make investment decisions for July 2026, before the results were filed, it has look-ahead bias. The strategy appears to know things that were not yet public information.<\/p>\n\n\n\n This is why point-in-time data<\/strong> is essential. Every data point used in a backtest must reflect what was actually available to an investor at the exact moment the simulated decision was made, not what was later reported, revised, or restated. Revenue figures get restated. EPS estimates get revised. Index constituents get updated retroactively. A backtest that does not handle these correctly produces results that are literally impossible to have achieved.<\/p>\n\n\n\n Overfitting is the subtlest and most intellectually dangerous of the biases. It happens when a strategy is designed, consciously or unconsciously, by tweaking parameters until the backtest looks good, rather than starting from a logical thesis and testing it.<\/p>\n\n\n\n With enough parameters and enough tweaking, you can always make a strategy look impressive on historical data. Change the momentum lookback from 6 months to 7 months. Adjust the P\/E threshold from 25 to 22. Add a market cap filter. Each tweak improves the backtest slightly. By the time you have made twenty such adjustments, the strategy fits the historical data perfectly, and will almost certainly fail going forward, because you have optimised for noise rather than signal.<\/p>\n\n\n\n The antidote to overfitting is twofold. First, start from an economic or behavioural rationale<\/strong>, use factors and thresholds that have logical explanations for why they should work, not just ones that happened to work in your specific dataset. Second, test the strategy across multiple market regimes<\/strong>, bull markets, bear markets, sideways markets, high-volatility periods, and check that it holds up reasonably across all of them rather than working spectacularly in one specific period.<\/p>\n\n\n\n A well-constructed backtest generates dozens of metrics. Not all of them are equally important. Here is a structured guide to reading a backtest report \u2014 organised from the metrics that matter most to those that provide supporting context.<\/p>\n\n\n\n The first and most obvious question: does the strategy beat the benchmark? CAGR (Compound Annual Growth Rate)<\/strong> is the annualised return of the strategy over the backtest period. Comparing it to the benchmark CAGR tells you whether the strategy adds value above simply holding an index fund.<\/p>\n\n\n\n A strategy that delivers 18% CAGR against a benchmark CAGR of 13% has outperformed by 5 percentage points annually. Compounded over 5 years, that is the difference between a \u20b910 lakh investment growing to \u20b922.9 lakh (strategy) versus \u20b918.5 lakh (benchmark).<\/p>\n\n\n\n However, CAGR alone is insufficient. A strategy with a higher CAGR that also has significantly higher volatility and deeper drawdowns may not be worth the additional risk \u2014 which is why the metrics below are necessary complements.<\/p>\n\n\n\n Cumulative return shows the total gain from the start to the end of the backtest period, not annualised. It is the simplest expression of what happened to a notional investment. Seeing a portfolio grow from \u20b910 lakh to \u20b924 lakh (+141%) against a benchmark growth of 37%<\/strong> over the same period immediately communicates the magnitude of outperformance in terms any investor can understand.<\/p>\n\n\n\n Maximum drawdown (Max DD) measures the largest peak-to-trough decline in the portfolio’s value over the backtest period, the worst loss you would have experienced if you had invested at the worst possible time. This is the most important risk metric<\/strong> in a backtest.<\/p>\n\n\n\n A strategy with a Max DD of \u201335% is telling you: at some point in the backtest, if you had invested at the peak, you would have watched your portfolio lose 35% of its value before recovering. The question you must honestly answer is: could you have held through that?<\/strong> An investor who would have sold during a 35% drawdown \u2014 which most retail investors would \u2014 cannot practically use a strategy that requires holding through one.<\/p>\n\n\n\n Always compare the strategy’s Max DD to the benchmark’s Max DD. A strategy with a higher CAGR but also a significantly higher Max DD is taking on more risk to generate those returns. Whether that trade-off is acceptable depends entirely on your risk tolerance.<\/p>\n\n\n\n The Sharpe Ratio<\/strong> measures how much excess return the strategy generates for each unit of volatility it takes on. A higher Sharpe Ratio means more return per unit of risk, a more efficient strategy. The formula is: (Strategy Return \u2013 Risk-Free Rate) \u00f7 Standard Deviation of Returns.<\/p>\n\n\n\n As a rough guide: a Sharpe Ratio above 1.0 is generally considered good for an equity strategy; above 1.5 is strong. A strategy with a Sharpe of 1.3 vs a benchmark Sharpe of 0.5 is delivering significantly better risk-adjusted returns \u2014 not just higher raw returns, but higher returns relative to the volatility the investor has to absorb.<\/p>\n\n\n\n The Sortino Ratio is a refinement of the Sharpe Ratio. Where Sharpe penalises all volatility \u2014 both upside and downside \u2014 the Sortino Ratio only penalises downside volatility<\/strong> (returns below the minimum acceptable return). This is arguably more meaningful for investors who do not mind volatile upside but want to minimise volatile downside.<\/p>\n\n\n\n A strategy with a high Sortino Ratio relative to both its Sharpe and the benchmark’s Sortino indicates that most of its volatility is on the upside \u2014 the kind of volatility investors actually welcome.<\/p>\n\n\n\n Alpha measures the return generated by the strategy above and beyond what its market exposure would predict<\/strong>. A Beta of 1.03 and an Alpha of 20% means the strategy moved broadly in line with the market (beta close to 1) but generated 20 percentage points of additional annual return that cannot be explained by simply riding market direction. That additional return is the strategy’s value-add, its excess performance attributable to stock selection or timing rather than market exposure.<\/p>\n\n\n\n RoMaD (Return over Maximum Drawdown) is a practical risk-adjusted metric that divides the strategy’s annualised return by its maximum drawdown. It answers: for every rupee of maximum loss I would have had to absorb, how much annual return did I get?<\/p>\n\n\n\n A RoMaD of 1.4 means the strategy generated 1.4x its maximum drawdown in annual returns, a reasonable trade-off. The benchmark’s RoMaD is the comparison point. If the strategy’s RoMaD is significantly higher than the benchmark’s, the strategy is generating more return per unit of maximum downside risk \u2014 a strong signal of quality beyond raw performance.<\/p>\n\n\n\n Calendar year returns break the backtest into annual slices and compare the strategy against the benchmark year by year. This is one of the most revealing sections of any backtest report because it shows whether the outperformance is consistent or concentrated in one or two lucky years<\/strong><\/p>\n\n\n\n A strategy that outperformed in 2023 (+14% vs +12%), 2024 (+31% vs +16%), 2025 (+30% vs +8%), and 2026 YTD (+24% vs \u20132%) is demonstrating consistent outperformance across multiple different market environments \u2014 a bull year, a volatile year, and a down year. That consistency is far more meaningful than a single year of spectacular outperformance with mediocre performance in all others.<\/p>\n\n\n\n Pay particular attention to down-market years<\/strong>, years where the benchmark was negative or flat. A good strategy should ideally show smaller losses than the benchmark in bad years (capital protection) while delivering larger gains in good years (upside participation). If the strategy only outperforms in strong bull markets but underperforms badly when markets fall, it is a leveraged market bet rather than a genuine alpha-generating strategy.<\/p>\n\n\n\n The trade summary shows the mechanics of how the strategy generates returns. Key metrics:<\/p>\n\n\n\n Win Rate:<\/strong> What percentage of individual trades were profitable. A win rate of 60% means 6 out of every 10 trades made money. Note that win rate alone is meaningless without knowing the average win and average loss sizes; a strategy with a 40% win rate but an average win 3x larger than the average loss is profitable overall.<\/p>\n\n\n\n Average Win vs Average Loss:<\/strong> The relationship between these two numbers is the strategy’s profit factor<\/strong>, the ratio of average gain to average loss. A strategy with an average win of 18% and an average loss of 4.5% has a profit factor of 4:1, meaning even with a win rate below 50%, the strategy is significantly profitable because winners are much larger than losers.<\/p>\n\n\n\n Total Trades:<\/strong> A low number of trades can make statistical significance questionable. A strategy that made 15 trades over 3 years may look impressive but does not have enough data points to draw reliable conclusions. A strategy with 500+ trades provides much stronger statistical evidence that the results are not due to chance.<\/p>\n\n\n\n Trailing returns show performance across multiple fixed windows ending on the backtest’s end date: month-to-date, 3 months, 6 months, 1 year, 3 years, 5 years. This is useful for understanding how the strategy has performed in recent periods relative to its longer-term average<\/strong>.<\/p>\n\n\n\n A strategy showing strong 1-year trailing returns that are significantly above its 3-year annualised CAGR is in a period of unusual outperformance, which may mean the strategy is overheated and due to revert, or it may reflect genuine acceleration. A strategy where recent trailing returns are below the long-term CAGR is in a period of relative underperformance, which may or may not be a concern depending on whether there is a logical reason for the weakness.<\/p>\n\n\n\nWhy Bias-Free, Point-in-Time Data Is Everything<\/strong><\/h2>\n\n\n\n
Survivorship Bias: The Most Common Trap<\/strong><\/h3>\n\n\n\n
Look-Ahead Bias: Using Information That Did Not Exist Yet<\/strong><\/h3>\n\n\n\n
Overfitting: Designing Rules That Work in the Past But Not the Future<\/strong><\/h3>\n\n\n\n
How to Read a Backtest Report: The Metrics That Matter<\/strong><\/h2>\n\n\n\n
![\"\"](\"https:\/\/sharpely.in\/blogs\/wp-content\/uploads\/2026\/09\/image-4-1024x540.png\")
<\/figure>\n\n\n\n1. CAGR vs Benchmark CAGR: Does the Strategy Actually Outperform?<\/strong><\/h3>\n\n\n\n
2. Cumulative Return: The Absolute Picture<\/strong><\/h3>\n\n\n\n
![\"\"](\"https:\/\/sharpely.in\/blogs\/wp-content\/uploads\/2026\/09\/image-5-1024x390.png\")
<\/figure>\n\n\n\n3. Maximum Drawdown: The Worst You Would Have Experienced<\/strong><\/h3>\n\n\n\n
4. Sharpe Ratio: Return Per Unit of Risk<\/strong><\/h3>\n\n\n\n
5. Sortino Ratio: Penalising Only Downside Volatility<\/strong><\/h3>\n\n\n\n
6. Alpha: What the Strategy Added Beyond Market Exposure<\/strong><\/h3>\n\n\n\n
7. RoMaD: Return Over Maximum Drawdown<\/strong><\/h3>\n\n\n\n
8. Calendar Year Returns: Does It Hold Up Across Different Markets?<\/strong><\/h3>\n\n\n\n
![\"\"](\"https:\/\/sharpely.in\/blogs\/wp-content\/uploads\/2026\/09\/image-6-1024x237.png\")
<\/figure>\n\n\n\n9. Trade Summary Metrics: The Mechanical Reality<\/strong><\/h3>\n\n\n\n
![\"\"](\"https:\/\/sharpely.in\/blogs\/wp-content\/uploads\/2026\/09\/image-7-1024x540.png\")
<\/figure>\n\n\n\n10. Trailing Returns: How It Looks Across Different Time Windows<\/strong><\/h3>\n\n\n\n
![\"\"](\"https:\/\/sharpely.in\/blogs\/wp-content\/uploads\/2026\/09\/image-8-1024x507.png\")
<\/figure>\n\n\n\nAdvanced Risk Metrics: What the Numbers Below the Headline Tell You<\/strong><\/h2>\n\n\n\n